Innocan Pharma Corporation (CSE:INNO) announced Monday that 90% of participants in a clinical study of the company’s Relief & Go over-the-counter (OTC) spray experienced a reduction in pain 24 hours after use.
The study, conducted by the Center for Podiatric Care & Sports Medicine in New York, included 18 people with pain ranging in area from the upper back to the feet.
After 20 minutes, 83% of participants noticed improvement, the company said, which jumped to 95% after an hour. After a full 24 hours, 90% described relief from pain.
READ: Innocan Pharma's cosmetic clinical study indicates 90% wrinkle reduction in volunteers using SHIR Premium CBD Facial Serum
Fifteen of the 18 participants would recommend the spray, the company said.
"We are thrilled that our clinical test yielded such promising results," CEO Iris Bincovich said in a statement. "Our unique approach and deep experience is exemplified in these impressive results that I'm certain are only the beginning."
The test was run by Joself Geldwert, who has more than 40 years of experience in foot surgery, biomechanics and sports injuries. He also serves on Innocan’s scientific advisory committee.
"I have been following up with patients who I have been seeing for foot and ankle related problems that have been using Relief & Go pain relief spray, and their responses have been positive,” Geldwert said. “I am impressed by how well patients have been doing with a non-prescriptive OTC pain relief spray."
Innocan's pain relief formulation contains a combination of magnesium oil, methyl salicylate, menthol and CBD, administered with a simple dose of spray, roll-on or lotion. Relief & Go spray is designed to target pain-related muscle and provide relief for joint pain.
Contact Andrew Kessel at firstname.lastname@example.org
Follow him on Twitter @andrew_kessel